Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard H. Greengold
Richard H. Greengold
Medicine
Oncology
Pathology
Antigen
Sipuleucel-T
3
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Open-label, multicenter study of sipuleucel-T in men with metastatic castrate-resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data.
2017
Journal of Clinical Oncology
Tomasz M. Beer
L. Michael Glode
Raymond S. Lance
Richard H. Greengold
Corazon P. dela Rosa
Robert Brownell Sims
Yang Wang
Nadeem A. Sheikh
John M. Corman
Show All
Source
Cite
Save
Citations (0)
P10-1 open-label, multicenter study of sipuleucel-T in metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) previously treated with sipuleucel-T: Evaluation of antigen-presenting cell (APC) activation.
2013
Journal of Clinical Oncology
Tomasz M. Beer
L. Michael Glode
Raymond S. Lance
Richard H. Greengold
Robert Brownell Sims
Yang Wang
Nadeem A. Sheikh
John M. Corman
Show All
Source
Cite
Save
Citations (1)
Managed care vs universal health insurance: whose whips are gentler?
2000
JAMA Internal Medicine
Richard H. Greengold
Show All
Source
Cite
Save
Citations (1)
1